4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-02 12:08 UTC
Taysha Gene Therapies announced an inducement grant under Nasdaq Listing Rule 5635(c)(4). The company is a clinical-stage biotechnology firm focused on AAV-based gene therapies for severe monogenic CNS diseases.
News 2026-10-02 12:00 UTC
Taysha Gene Therapies said it granted inducement awards under Nasdaq Listing Rule 5635(c)(4).
News 2026-09-04 12:07 UTC
Taysha Gene Therapies, Inc. announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
News 2026-09-04 12:00 UTC
Taysha Gene Therapies said it announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).